Farnesoid X receptor (FXR) as a potential therapeutic target in nonalcoholic fatty liver disease and associated syndromes

Nonalcoholic fatty liver disease (NAFLD) is a group of obesity-associated pathological changes characterized by abnormal accumulation of lipids in cells of the liver parenchyma. NAFLD and associated conditions, namely insulin resistance and type II diabetes mellitus (DM2), as well as the possible ri...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Apollinariya V. Bogolyubova, Alexander Y. Mayorov, Ekaterina E. Mishina, Anton M. Schwartz, Pavel V. Belousov
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Endocrinology Research Centre 2017-12-01
Edice:	Сахарный диабет
Témata:	nonalcoholic fatty liver disease nonalcoholic steatohepatitis farnesoid x
On-line přístup:	https://www.dia-endojournals.ru/jour/article/view/9374
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!